What is Jon Rowley email address?

Jon Rowley's primary email address is *******@roosterbio.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Jon Rowley work for?

Jon Rowley is a Engineering Consultant at BioLife Solutions, Inc..

Where Jon Rowley graduated from?

Jon Rowley holds a degree in •Research Focus: Designing biomaterials to control cell function and engineered tissue development: -New materials were licensed and developed pre-clinically at Curis, Inc. -IP now owned and materials commercialized by FMC Biopolymer, with whom I scientifically consult •15 publications, 4 patent apps., 3 issued patents, and 23 national meeting presentations •Created novel biomaterial systems for studying cell adhesion, cell mechanics, and scaffold interactions •Developed cell-based system for investigating signals controlling growth and differentiation in muscle cells •Extensively interacted with industry and academic collaborators outside UM •Awarded competitive training fellowships: GAANN Fellowship (1995–1996) Cellular Biotechnology Training Fellowship (2000–2001) Show less from University of Michigan.

How can I directly contact Jon Rowley?

To contact Jon Rowley directly, you can use the email address *******@roosterbio.com. Complete contact information is available upon registration with Muraena.

Who is Jon Rowley?

Jon Rowley is a dynamic life science entrepreneur and the Founder & Chief Product Officer at RoosterBio Inc., where he has been instrumental in advancing cell therapy manufacturing processes. With a strong background in materials science and engineering, he has dedicated his career to simplifying the integration of human mesenchymal stem cells (hMSCs) into regenerative medicine. Jon's expertise spans across various domains including biotechnology, innovation, and strategic growth, which he leverages to mentor emerging companies as a board member and advisor. His passion for longevity, synthetic biology, and the intersection of technology and biology fuels his innovative approach to product development. Jon's commitment to driving progress in the biotech sector has earned him recognition, including an Innovation Award from Lonza. He actively participates in scientific advisory boards, contributing to the advancement of the advanced therapies industry.